A Pilot Study of Intensive Insulin Regimen as a Primary Treatment of New Onset of Type 2 DM.
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2014
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INSPIRE
- 10 Jun 2017 Biomarkers information updated
- 07 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 Oct 2010 Actual initiation date (Jul 2010) added as reported by ClinicalTrials.gov.